Up next

Autoplay

Tocilizumab | Treating Inflammatory Disorders and Cytokine Release Storm | Medindia

0 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Source: https://www.medindia.net/docto....rs/drug_information/

**Tocilizumab for Treating Inflammatory disorders&cytokine release storm**

Tocilizumab is prescribed for treatingcytokine release storm that can occur with coronavirus or COVID-19 and other inflammatory disorders like rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (SJIA), Giant Cell Arteritis (GCA), Polyarticular Juvenile Idiopathic Arthritis (PJIA),

How does Tocilizumab work?
The drug blocks inflammation by inhibiting the actions of one of the major substance responsible for inflammation called IL-6,.

Trade name: Actemra

Classification: Tocilizumab is an immunomodulator.



**About Channel**

Medindia is a leading online provider of health information, applications and services for consumers, doctors, healthcare professionals globally.

Medindia, currently ranks #1 in India / South Asia in terms of traffic in the health category and among the top health sites in the world.

Medindia’s content is viewed by over 4 million visitors each month from over 230 countries. Medindia offers almost 1 million pages of trusted health and wellness information including news, special reports, articles, animations, slides, infographics, videos, health directories, drug information, calculators, personalized health record, mobile apps, interactive tools, applications and much more.


Social Media Handles:
Instagram: https://www.instagram.com/medindia/
Facebook: http://www.facebook.com/Medindia
Twitter: https://twitter.com/medindia
LinkedIn :http://www.linkedin.com/in/medindia
Tumblr :http://medindia.tumblr.com/

Languages:
Medindia English: https://medindia.net/
Medindia Hindi: https://hi.medindia.net/
Medindia Spanish: https://es.medindia.net/
Medindia Chinese: https://cn.medindia.net/

Show more
0 Comments sort Sort By

Up next

Autoplay